‘Hormone Therapy Warning: Irreversible Infertility Risk’ on Trans Clinic Waiver

Advocates Push for Lower Age for Gender-Affirming Care, But Waivers Reveal Alarming Side Effects

Advocates of so-called “gender affirming care” for children have sought to lower the minimum age for cross-sex hormone therapy, but waivers at a top Virginia clinic require parents to acknowledge a frightening list of potential permanent side effects.

The waivers from the University of Virginia (UVA) Medical Center, obtained exclusively by The Daily Wire, list the potentially harmful side effects of testosterone treatment and puberty blocker usage. The UVA Children’s Hospital Transgender Youth Health clinic offers “transgender youth health services for ages 11 to 25.”

Testosterone Therapy: Potential Side Effects

• Transient infertility
• Irreversible infertility
• High cholesterol
• Sleep apnea
• Increased risk of yeast infections

The consent form for testosterone therapy warns about the possibility of infertility and suggests banking eggs. It also states that the use of testosterone for gender transition is an “off-label” use not approved by the FDA.

Puberty Blockers: Potential Side Effects

• Compromised bone density
• Off-label use
• No long-term effects on fertility
• Limitations on fertility preservation options

The form highlights the potential impact of puberty blockers on bone density and fertility. It emphasizes that puberty blockers are also used off-label and not FDA-approved.

Despite the risks of permanent infertility and other side effects, the World Professional Association for Transgender Health (WPATH) initially recommended cross-sex hormone treatments for children as young as 14. However, they later retracted this recommendation.

Detransitioner Chloe Cole, who began transitioning at 13, shared her experience of the lax process to obtain puberty blockers and cross-sex hormones. She expressed concerns about the lack of information provided about fertility preservation options and the vague terms used to describe side effects.

Dr. Stanley Goldfarb, the board chair of Do No Harm, raised concerns about the coercion of parents into signing waivers for gender-affirming interventions. He questioned whether parents were fully informed about the risks and whether the decision-making process was influenced by the fear of suicide.

January Littlejohn, a parent advocate at Do No Harm, emphasized the need for thorough assessments and protection of adolescents from irreversible harms caused by experimental interventions.

Psychologist Erica Anderson resigned from her role as a board member of WPATH after witnessing rushed consultations and families reporting minimal interaction with doctors before being offered cross-sex hormone therapy.

Meanwhile, detransitioners like Chloe Cole, Layla Jane, and Kayla Lovdahl are suing medical institutions for providing them with treatments that resulted in irreversible changes.

UVA Health did not respond to a request for comment.

*As an Amazon Associate I earn from qualifying purchases